Hepatitis: all 3,372 studies
Page 23 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive ParametersCompletedNCT01962155
- An Observational Study of Hepatitis C Virus in PregnancyCompletedNCT01959321
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Therapeutic Option for Hepatitis B and C: a French CohortStatus unknownNCT01953458
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisTerminatedNCT01951209Not applicable
- The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A VaccinesCompletedNCT01949857Phase 4
- A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCVStatus unknownNCT01949168Phase 2
- Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.WithdrawnNCT01949077
- Phase 3 and Extensional Study of BesifovirStatus unknownNCT01937806Phase 3
- A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
- Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease PatientsStatus unknownNCT01933412Phase 3
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyCompletedNCT01928511Phase 4
- A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C PatientsCompletedNCT01928147Phase 1
- PCV13 + Hepatitis a Vaccine for AdultsCompletedNCT01926860Phase 4
- Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- The Pathogenesis of Hepatitis C Virus Vertical TransmissionCompletedNCT01921400
- Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)CompletedNCT01919125Phase 1
- Protective Immune Mechanisms in Alcoholic HepatitisCompletedNCT01918462
- A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectCompletedNCT01917357Phase 3
- Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
- Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus RibavirinCompletedNCT01913964Phase 4
- Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis BCompletedNCT01913431Phase 4
- Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide AnaloguesStatus unknownNCT01911156Phase 4
- Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life ConditionsCompletedNCT01908660
- A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis CCompletedNCT01908335Phase 2
- Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)CompletedNCT01907724Phase 1
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis PatientsStatus unknownNCT01907230Phase 4
- Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BStatus unknownNCT01906580Phase 4
- A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis CCompletedNCT01903954Phase 2
- Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis CCompletedNCT01903278Phase 3
- Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis CStatus unknownNCT01900886
- Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis CCompletedNCT01899092Phase 1/2
- Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian PopulationStatus unknownNCT01896609Phase 4
- Hepatitis B Vaccination in InfantsCompletedNCT01896596Phase 4
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
- Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1WithdrawnNCT01890772Phase 2/3
- The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)WithdrawnNCT01890200Phase 3
- A Health Intervention to Prevent Depression Hepatitis C PatientsTerminatedNCT01890083Phase 2/3
- An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis CCompletedNCT01889433Phase 3
- A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis BCompletedNCT01887275Phase 4
- Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic CirrhosisCompletedNCT01884415Phase 3
- Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4CompletedNCT01884402
- A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy SubjectsCompletedNCT01879462Phase 1
- The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg SeroconversionStatus unknownNCT01878565Phase 1/2
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus InfectionStatus unknownNCT01872936Phase 2
- Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis CWithdrawnNCT01871662Phase 2/3
- Evaluation of Role of Transient Elastography (Fibroscan) in Differentiating Patients of Acute Severe Viral Hepatitis and Acute on Chronic Liver FailureStatus unknownNCT01866072
- Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young AdultsCompletedNCT01865968Phase 4
- Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College StudentsCompletedNCT01861613Phase 4
- An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)TerminatedNCT01861444
- Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis CCompletedNCT01859962Phase 2
- Open Label Trial to Compare BI 207127 to Telaprevir in HCV PatientsWithdrawnNCT01858961Phase 3
- Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C SubjectsCompletedNCT01856426Phase 1
- A Clinical Trial of Zutectra in Patients Who Recently Received a Liver TransplantCompletedNCT01856413Phase 3
- Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)CompletedNCT01852604Phase 2
- Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute ExacerbationStatus unknownNCT01848743Phase 3
- A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionCompletedNCT01846832Phase 3
- UCLA-Amity Parolee Health Promotion StudyCompletedNCT01844414Not applicable
- Interferon α 2b Pharmacovigilance StudyCompletedNCT01841775Phase 4
- Interaction Between Paroxetine and TelaprevirTerminatedNCT01841502Phase 2
- HCV Treatment in HIV Co-Infected Patients in AsiaCompletedNCT01838772Phase 4
- Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)CompletedNCT01838070
- Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver TransplantationStatus unknownNCT01836718
- Clinical Investigation of Erlotinib as an HCV Entry InhibitorStatus unknownNCT01835938Phase 1/2
- Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALTStatus unknownNCT01833611Phase 4
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver FailureCompletedNCT01826760
- Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected PatientsCompletedNCT01825980Phase 1/2
- New Methods to Measure the Immune Response to Hepatitis B VaccineCompletedNCT01821547Phase 4
- Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic HepatitisCompletedNCT01820208Not applicable
- Pharmacokinetic Interactions Between Telaprevir and Un-boosted AtazanavirCompletedNCT01818856Phase 1
- A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic ImpairmentCompletedNCT01817985Phase 1
- THISTLE - The HIV-HCV Silibinin TrialCompletedNCT01816490Phase 2
- To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)CompletedNCT01813552Phase 1
- Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)CompletedNCT01813513Phase 1
- Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk FactorsWithdrawnNCT01813266
- Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination.CompletedNCT01810835
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.CompletedNCT01804829Phase 3
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
- A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C InfectionCompletedNCT01803308Phase 1
- Intensive Enteral Nutrition and Acute Alcoholic HepatitisCompletedNCT01801332Not applicable
- An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment FailureTerminatedNCT01798576
- Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve PatientsWithdrawnNCT01797848Phase 3
- Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinCompletedNCT01795911Phase 2
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) AnaloguesTerminatedNCT01794234
- A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01790100Phase 2
- Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
- Acceptability of Hepatitis B Vaccination in General PopulationCompletedNCT01782794
- Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CApproved for marketingNCT01779518
- Acceptability of Hepatitis B Vaccination in General Practitioners and PaediatriciansCompletedNCT01777074
- Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in KoreaStatus unknownNCT01776814
- Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in IndiaCompletedNCT01772121
- Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C InfectionCompletedNCT01771653
- A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)WithdrawnNCT01770223Phase 4
- HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside MaintenanceStatus unknownNCT01769833Phase 3